Article info

Download PDFPDF
Original article
ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitis

Authors

  • Abdo Mahli Department of Internal Medicine I, University Hospital Regensburg, Regensburg, Germany Institute of Biochemistry (Emil-Fischer Zentrum), Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Michael Saugspier Department of Internal Medicine I, University Hospital Regensburg, Regensburg, Germany PubMed articlesGoogle scholar articles
  • Andreas Koch Department of Internal Medicine I, University Hospital Regensburg, Regensburg, Germany Institute of Biochemistry (Emil-Fischer Zentrum), Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Judith Sommer Department of Internal Medicine I, University Hospital Regensburg, Regensburg, Germany Institute of Biochemistry (Emil-Fischer Zentrum), Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Peter Dietrich Institute of Biochemistry (Emil-Fischer Zentrum), Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Seren Lee Biobank o.b. HTCR, Department of General Visceral- and Transplantation Surgery, Ludwig-Maximilians-University Munich, Munich, Germany PubMed articlesGoogle scholar articles
  • Reinhard Thasler Biobank o.b. HTCR, Department of General Visceral- and Transplantation Surgery, Ludwig-Maximilians-University Munich, Munich, Germany PubMed articlesGoogle scholar articles
  • Jan Schulze-Luehrmann Mikrobiologisches Institut – Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Anja Luehrmann Mikrobiologisches Institut – Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Wolfgang Erwin Thasler Biobank o.b. HTCR, Department of General Visceral- and Transplantation Surgery, Ludwig-Maximilians-University Munich, Munich, Germany PubMed articlesGoogle scholar articles
  • Martina Müller Department of Internal Medicine I, University Hospital Regensburg, Regensburg, Germany PubMed articlesGoogle scholar articles
  • Anja Bosserhoff Institute of Biochemistry (Emil-Fischer Zentrum), Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany Comprehensive Cancer Center Erlangen, CCC Erlangen-EMN, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Claus Hellerbrand Department of Internal Medicine I, University Hospital Regensburg, Regensburg, Germany Institute of Biochemistry (Emil-Fischer Zentrum), Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Claus Hellerbrand, Institute of Biochemistry, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen D-91054, Germany; claus.hellerbrand{at}fau.de
View Full Text

Citation

Mahli A, Saugspier M, Koch A, et al
ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitis

Publication history

  • Received June 22, 2016
  • Revised December 7, 2016
  • Accepted December 8, 2016
  • First published January 4, 2017.
Online issue publication 
July 25, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.